The Claim
In adults with obesity (BMI ≥30 kg/m² or ≥27 kg/m² with comorbidities), a 72-week combination of intravenous bimagrumab (30 mg/kg every 12 weeks) and subcutaneous semaglutide (2.4 mg weekly) results in a mean weight loss of 24.2 kg and a 45.7% reduction in total body fat mass, while preserving lean mass, and produces greater weight loss and fat mass reduction than subcutaneous semaglutide (2.4 mg weekly) alone, which results in a mean weight loss of 16.5 kg and a 27.8% reduction in total body fat mass.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In adults with obesity, a 72-week treatment combining bimagrumab and semaglutide leads to an average weight loss of 24.2 kg and a 45.7% reduction in body fat while maintaining muscle mass, which is greater than the weight loss and fat reduction seen with semaglutide alone.
See the scientific wording
In adults with obesity (BMI ≥30 kg/m² or ≥27 kg/m² with comorbidities), a 72-week combination of intravenous bimagrumab (30 mg/kg every 12 weeks) and subcutaneous semaglutide (2.4 mg weekly) results in a mean weight loss of 24.2 kg and a 45.7% reduction in total body fat mass, while preserving lean mass, surpassing the effects of semaglutide alone, which achieved 16.5 kg weight loss and 27.8% fat mass reduction.
A drug blocks signals that tell fat cells to store energy and muscle cells to break down, while another drug tells the brain to feel full and eat less. This causes the body to burn fat for energy without losing muscle, leading to greater fat loss and more muscle retention than just reducing food intake alone.
What the research says
1 studyIn people with obesity, taking both drugs together for a year lost more fat and weight than taking just one drug, and kept more muscle intact. The study proved this combo works better than the single drug alone.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.